Mostrar el registro sencillo del ítem

dc.contributor.authorNovella-Navarro, Marta
dc.contributor.authorCabrera-Alarcón, José Luis 
dc.contributor.authorRosales-Alexander, José Luis
dc.contributor.authorGonzález-Martín, Jorge Juan
dc.contributor.authorCarrión, Ofelia
dc.contributor.authorPeña, Paloma García de la
dc.date.accessioned2023-03-23T11:32:40Z
dc.date.available2023-03-23T11:32:40Z
dc.date.issued2022-01
dc.identifier.citationEur J Rheumatol. 2022 Jan;9(1):20-25es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15701
dc.description.abstractTo assess the prevalence of subclinical atherosclerosis in patients with primary Sjögren's syndrome (pSS) and its possible association with clinical and analytical parameters of the disease. In this cross-sectional study, 38 consecutive patients with pSS were compared with 38 age and sex healthy controls. Demographic variables and classic cardiovascular risk factors (CVRFs): Hypertension, dyslipidemia, diabetes mellitus, obesity, and smoking habit were assessed in both groups, and also disease-related features were collected in pSS group. The presence of subclinical atherosclerosis was assessed by carotid ultrasound, with carotid intima-media thickness (CIMT) measurement and determination of the presence of atheromatous plaques. Subclinical atherosclerosis presence was remarkably greater in patients with pSS than in healthy controls (OR = 4.17, 95%CI [1.27-16.54]), as well as CIMT values (0.79 ± 0.43mm vs. 0.66 ± 0.27mm; P = .02). No differences for classic CVRFs were found between both groups. An association of subclinical atherosclerosis with erythrocyte sedimentation rate (ESR) and rheumatoid factor (RF) was observed in patients with pSS. This cohort showed a greater prevalence of subclinical atherosclerosis in patients with pSS, indicating this disease as an independent risk factor for presence of early vascular damage.es_ES
dc.description.sponsorshipThe authors declared that this study has received no financial support.es_ES
dc.language.isoenges_ES
dc.publisherAVESes_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titlePrimary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID35110133es_ES
dc.format.volume9es_ES
dc.format.number1es_ES
dc.format.page20es_ES
dc.identifier.doi10.5152/eurjrheum.2021.20093es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2148-4279es_ES
dc.relation.publisherversion10.5152/eurjrheum.2021.20093es_ES
dc.identifier.journalEuropean journal of rheumatologyes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Genética Funcional del Sistema de Fosforilación Oxidativaes_ES
dc.repisalud.institucionCNICes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 Internacional